JP2025517683A5 - - Google Patents

Info

Publication number
JP2025517683A5
JP2025517683A5 JP2024566556A JP2024566556A JP2025517683A5 JP 2025517683 A5 JP2025517683 A5 JP 2025517683A5 JP 2024566556 A JP2024566556 A JP 2024566556A JP 2024566556 A JP2024566556 A JP 2024566556A JP 2025517683 A5 JP2025517683 A5 JP 2025517683A5
Authority
JP
Japan
Prior art keywords
compound
day
formula
dose
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025517683A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2023/054527 external-priority patent/WO2023218285A1/en
Publication of JP2025517683A publication Critical patent/JP2025517683A/ja
Publication of JP2025517683A5 publication Critical patent/JP2025517683A5/ja
Pending legal-status Critical Current

Links

JP2024566556A 2022-05-12 2023-05-01 デングウイルス感染症の治療及び/又は予防 Pending JP2025517683A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263341074P 2022-05-12 2022-05-12
US63/341,074 2022-05-12
PCT/IB2023/054527 WO2023218285A1 (en) 2022-05-12 2023-05-01 Treatment or prevention of dengue viral infection

Publications (2)

Publication Number Publication Date
JP2025517683A JP2025517683A (ja) 2025-06-10
JP2025517683A5 true JP2025517683A5 (enExample) 2026-05-13

Family

ID=86558745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566556A Pending JP2025517683A (ja) 2022-05-12 2023-05-01 デングウイルス感染症の治療及び/又は予防

Country Status (8)

Country Link
US (1) US20250281457A1 (enExample)
EP (1) EP4522163A1 (enExample)
JP (1) JP2025517683A (enExample)
CN (1) CN119173261A (enExample)
AU (1) AU2023269343A1 (enExample)
CA (1) CA3257185A1 (enExample)
TW (1) TW202400144A (enExample)
WO (1) WO2023218285A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025253267A1 (en) 2024-06-06 2025-12-11 Janssen Pharmaceuticals, Inc. Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
CN114980884A (zh) * 2019-11-15 2022-08-30 杨森制药公司 登革热疾病的治疗和预防

Similar Documents

Publication Publication Date Title
JP6491174B2 (ja) ニタゾキサニドの制御放出医薬配合物
JP2022546471A5 (enExample)
JP2021519288A5 (enExample)
JP2005525369A5 (enExample)
JP2019515884A5 (enExample)
JP2020523335A5 (enExample)
JP2018504398A5 (enExample)
JP2020510660A5 (enExample)
JP2022533368A5 (enExample)
JP2024522817A5 (enExample)
JP2019512537A (ja) ダパグリフロジンの医薬組成物
JP2024522817A (ja) フェニルピロールアミノグアニジン塩及び製剤
CN103096881A (zh) 含有具有不愉快味道的药物的膜制剂
FI3706724T3 (fi) Suun kautta otettavia rifamysiini sv -koostumuksia
JP2022554276A5 (enExample)
JP2022535893A5 (enExample)
JP2021502382A5 (enExample)
ES2349998T3 (es) Preparado de liberación retardada en forma de comprimido que contiene cinarizina y dimenhidrinato contra el vértigo.
JP2023502053A5 (enExample)
JP2025509278A5 (enExample)
KR102568877B1 (ko) 중증열성혈소판감소증후군 치료 또는 예방용 약학 조성물 및 이의 의약 용도
JP2019085364A5 (enExample)
ES2349996T3 (es) Preparado de liberación retardada en forma de pellas que contiene cinarizina y dimenhidrinato contra el vértigo.
JP7355846B2 (ja) 固形製剤
JP2022524819A (ja) カプシド集合調節剤固体製剤